Pain management nursing : official journal of the American Society of Pain Management Nurses · 2025
Chronic Pain Prevalence, Characteristics, and Impact in United States Adults With Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Adamowicz Jenna L, Sirotiak Zoe, Lendvai Dora, Thomas Emily B K, Lund Brian C, Driscoll Mary A, Hadlandsmyth Katherine
Аннотация
PURPOSE: To determine the prevalence of chronic pain, describe characteristics of chronic pain, and examine the impact of chronic pain on quality-of-life in United States adults with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).
DESIGN: Secondary analysis of cross-sectional data from the 2023 National Health Interview Survey.
METHODS: Survey weights and variance estimation variables were employed. Pain duration over the past 3 months was used to determine whether individuals with CFS/ME were experiencing chronic pain. Rao-Scott chi-square test examined group-based differences between those with CFS/ME and chronic pain to those with chronic pain without CFS/ME across pain characteristics (intensity, location, limitations) and three quality-of-life domains (psychological health, general health, life satisfaction).
RESULTS: The proportion of United States adults who reported having CFS/ME was 1.4% (weighted). Of those with CFS/ME, 70.7% (weighted) met study criteria for chronic pain. Pain was common across multiple body locations among those with comorbid CFS/ME and chronic pain, and impacted multiple domains of functioning, including life/work activities and family relationships. Relative to those with chronic pain without CFS/ME, individuals with CFS/ME and chronic pain were significantly more likely to have positive results on depression and anxiety screeners, and report fair/poor general health and life dissatisfaction (ps < .05).
CONCLUSIONS: Chronic pain is common among individuals with CFS/ME and is associated with diminished quality-of-life. Although not all individuals with CFS/ME experience chronic pain, a prominent proportion do.
CLINICAL IMPLICATIONS: For those with comorbid CFS/ME and chronic pain, interventions targeting the management of multiple symptoms may be particularly important.
DESIGN: Secondary analysis of cross-sectional data from the 2023 National Health Interview Survey.
METHODS: Survey weights and variance estimation variables were employed. Pain duration over the past 3 months was used to determine whether individuals with CFS/ME were experiencing chronic pain. Rao-Scott chi-square test examined group-based differences between those with CFS/ME and chronic pain to those with chronic pain without CFS/ME across pain characteristics (intensity, location, limitations) and three quality-of-life domains (psychological health, general health, life satisfaction).
RESULTS: The proportion of United States adults who reported having CFS/ME was 1.4% (weighted). Of those with CFS/ME, 70.7% (weighted) met study criteria for chronic pain. Pain was common across multiple body locations among those with comorbid CFS/ME and chronic pain, and impacted multiple domains of functioning, including life/work activities and family relationships. Relative to those with chronic pain without CFS/ME, individuals with CFS/ME and chronic pain were significantly more likely to have positive results on depression and anxiety screeners, and report fair/poor general health and life dissatisfaction (ps < .05).
CONCLUSIONS: Chronic pain is common among individuals with CFS/ME and is associated with diminished quality-of-life. Although not all individuals with CFS/ME experience chronic pain, a prominent proportion do.
CLINICAL IMPLICATIONS: For those with comorbid CFS/ME and chronic pain, interventions targeting the management of multiple symptoms may be particularly important.